BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28228265)

  • 1. E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.
    Benini M; Fortuni S; Condò I; Alfedi G; Malisan F; Toschi N; Serio D; Massaro DS; Arcuri G; Testi R; Rufini A
    Cell Rep; 2017 Feb; 18(8):2007-2017. PubMed ID: 28228265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.
    Rufini A; Fortuni S; Arcuri G; Condò I; Serio D; Incani O; Malisan F; Ventura N; Testi R
    Hum Mol Genet; 2011 Apr; 20(7):1253-61. PubMed ID: 21216878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells.
    Rufini A; Cavallo F; Condò I; Fortuni S; De Martino G; Incani O; Di Venere A; Benini M; Massaro DS; Arcuri G; Serio D; Malisan F; Testi R
    Neurobiol Dis; 2015 Mar; 75():91-9. PubMed ID: 25549872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich ataxia cellular models.
    Dong YN; McMillan E; Clark EM; Lin H; Lynch DR
    Hum Mol Genet; 2019 May; 28(10):1594-1607. PubMed ID: 30590615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain.
    Doni D; Cavion F; Bortolus M; Baschiera E; Muccioli S; Tombesi G; d'Ettorre F; Ottaviani D; Marchesan E; Leanza L; Greggio E; Ziviani E; Russo A; Bellin M; Sartori G; Carbonera D; Salviati L; Costantini P
    Cell Death Dis; 2023 Dec; 14(12):805. PubMed ID: 38062036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
    Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
    Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
    Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.
    Calmels N; Seznec H; Villa P; Reutenauer L; Hibert M; Haiech J; Rustin P; Koenig M; Puccio H
    BMC Neurol; 2009 Aug; 9():46. PubMed ID: 19703283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
    Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
    J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol increases frataxin levels and restores mitochondrial function in cell models of Friedreich Ataxia.
    Britti E; Delaspre F; Sanz-Alcázar A; Medina-Carbonero M; Llovera M; Purroy R; Mincheva-Tasheva S; Tamarit J; Ros J
    Biochem J; 2021 Jan; 478(1):1-20. PubMed ID: 33305808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts.
    Kemp K; Mallam E; Hares K; Witherick J; Scolding N; Wilkins A
    PLoS One; 2011; 6(10):e26098. PubMed ID: 22016819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation.
    Zhi X; Zhao D; Wang Z; Zhou Z; Wang C; Chen W; Liu R; Chen C
    Cancer Res; 2013 Jan; 73(1):385-94. PubMed ID: 23026136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF126-Mediated Reubiquitination Is Required for Proteasomal Degradation of p97-Extracted Membrane Proteins.
    Hu X; Wang L; Wang Y; Ji J; Li J; Wang Z; Li C; Zhang Y; Zhang ZR
    Mol Cell; 2020 Jul; 79(2):320-331.e9. PubMed ID: 32645369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones.
    Shan Y; Napoli E; Cortopassi G
    Hum Mol Genet; 2007 Apr; 16(8):929-41. PubMed ID: 17331979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo mitochondrial two-step maturation of human frataxin.
    Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H
    Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No changes in heme synthesis in human Friedreich´s ataxia erythroid progenitor cells.
    Steinkellner H; Singh HN; Muckenthaler MU; Goldenberg H; Moganty RR; Scheiber-Mojdehkar B; Sturm B
    Gene; 2017 Jul; 621():5-11. PubMed ID: 28412459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich ataxia: an update on animal models, frataxin function and therapies.
    González-Cabo P; Llorens JV; Palau F; Moltó MD
    Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic developments in Friedreich ataxia.
    Wilson RB
    J Child Neurol; 2012 Sep; 27(9):1212-6. PubMed ID: 22791549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.